Insights into the Role of LncRNAs and MiRNAs in Glioma Progression and Their Potential As Novel Therapeutic Targets

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 Jul 14

PMID 37444408

Authors

Mateusz Kciuk

Esam Bashir Yahya

Montaha Mohamed Ibrahim Mohamed

Muhanad A Abdulsamad

Abdulmutalib A Allaq

Adrianna Gielecinska

Renata Kontek

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence supports that both long non-coding and micro RNAs (lncRNAs and miRNAs) are implicated in glioma tumorigenesis and progression. Poor outcome of gliomas has been linked to late-stage diagnosis and mostly ineffectiveness of conventional treatment due to low knowledge about the early stage of gliomas, which are not possible to observe with conventional diagnostic approaches. The past few years witnessed a revolutionary advance in biotechnology and neuroscience with the understanding of tumor-related molecules, including non-coding RNAs that are involved in the angiogenesis and progression of glioma cells and thus are used as prognostic biomarkers as well as novel therapeutic targets. The emerging research on lncRNAs and miRNAs highlights their crucial role in glioma progression, offering new insights into the disease. These non-coding RNAs hold significant potential as novel therapeutic targets, paving the way for innovative treatment approaches against glioma. This review encompasses a comprehensive discussion about the role of lncRNAs and miRNAs in gene regulation that is responsible for the promotion or the inhibition of glioma progression and collects the existing links between these key cancer-related molecules.

Citing Articles

The role of lncRNAs in the interplay of signaling pathways and epigenetic mechanisms in glioma.

Bora Yildiz C, Du J, Mohan K, Zimmer-Bensch G, Abdolahi S Epigenomics. 2025; 17(2):125-140.

PMID: 39829063 PMC: 11792803. DOI: 10.1080/17501911.2024.2442297.

Epigenetic Biomarkers in Thrombophilia-Related Pregnancy Complications: Mechanisms, Diagnostic Potential, and Therapeutic Implications: A Narrative Review.

Bardan C, Ionita I, Iordache M, Calamar-Popovici D, Todorescu V, Popescu R Int J Mol Sci. 2025; 25(24.

PMID: 39769397 PMC: 11728153. DOI: 10.3390/ijms252413634.

Genomic, epigenomic and transcriptomic landscape of glioblastoma.

Dakal T, Kakde G, Maurya P Metab Brain Dis. 2024; 39(8):1591-1611.

PMID: 39180605 DOI: 10.1007/s11011-024-01414-8.

Hidden regulators: the emerging roles of lncRNAs in brain development and disease.

Alammari F, Al-Hujaily E, Alshareeda A, Albarakati N, Al-Sowayan B Front Neurosci. 2024; 18:1392688.

PMID: 38841098 PMC: 11150811. DOI: 10.3389/fnins.2024.1392688.

References

Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J . Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6. Oncotarget. 2017; 8(15):24949-24963. PMC: 5421901. DOI: 10.18632/oncotarget.15327. View

Wang W, Wu F, Zhao Z, Wang K, Huang R, Wang H . Long noncoding RNA LINC00152 is a potential prognostic biomarker in patients with high-grade glioma. CNS Neurosci Ther. 2018; 24(10):957-966. PMC: 6489806. DOI: 10.1111/cns.12850. View

Franklin K, Shields C, Haynes K . Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering. Trends Biochem Sci. 2022; 47(5):417-432. PMC: 9074927. DOI: 10.1016/j.tibs.2022.03.002. View

Jiang J, Yang J, Wang Z, Wu G, Liu F . TFAM is directly regulated by miR-23b in glioma. Oncol Rep. 2013; 30(5):2105-10. DOI: 10.3892/or.2013.2712. View

Qin N, Tong G, Sun L, Xu X . Long Noncoding RNA MEG3 Suppresses Glioma Cell Proliferation, Migration, and Invasion by Acting as a Competing Endogenous RNA of miR-19a. Oncol Res. 2017; 25(9):1471-1478. PMC: 7841124. DOI: 10.3727/096504017X14886689179993. View

Liu X, Wang S, Yuan A, Yuan X, Liu B . MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9. Oncol Rep. 2016; 36(4):2329-38. DOI: 10.3892/or.2016.5007. View

Sun G, Cao Y, Shi L, Sun L, Wang Y, Chen C . Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. Cancer Biother Radiopharm. 2014; 28(4):327-34. PMC: 3653372. DOI: 10.1089/cbr.2012.1380. View

Yan Z, Che S, Wang J, Jiao Y, Wang C, Meng Q . miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway. Tumour Biol. 2015; 36(7):5323-31. DOI: 10.1007/s13277-015-3193-9. View

Cates K, McCoy M, Kwon J, Liu Y, Abernathy D, Zhang B . Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs. Cell Stem Cell. 2020; 28(1):127-140.e9. PMC: 7796891. DOI: 10.1016/j.stem.2020.08.015. View

10.

Khan S, Mittal S, McGee K, Alfaro-Munoz K, Majd N, Balasubramaniyan V . Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance. Int J Mol Sci. 2020; 21(6). PMC: 7139844. DOI: 10.3390/ijms21061954. View

11.

Cai H, Liu X, Zheng J, Xue Y, Ma J, Xi Z . Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene. 2016; 36(3):318-331. DOI: 10.1038/onc.2016.212. View

12.

Wen H, Li Z, Song S, Xu L, Tong X, Yan H . Silencing of lncRNA LBX2-AS1 suppresses glioma cell proliferation and metastasis through the Akt/GSK3β pathway in vitro. Acta Biochim Biophys Sin (Shanghai). 2021; 53(4):446-453. DOI: 10.1093/abbs/gmab011. View

13.

Yu B, Wang S . Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease. Theranostics. 2018; 8(13):3654-3675. PMC: 6037039. DOI: 10.7150/thno.26024. View

14.

Reuss D . Updates on the WHO diagnosis of IDH-mutant glioma. J Neurooncol. 2023; 162(3):461-469. PMC: 10227121. DOI: 10.1007/s11060-023-04250-5. View

15.

Gong W, Zheng J, Liu X, Ma J, Liu Y, Xue Y . Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e. Oncotarget. 2016; 7(38):62208-62223. PMC: 5308721. DOI: 10.18632/oncotarget.11403. View

16.

Schulte J, Horn S, Otto T, Samans B, Heukamp L, Eilers U . MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer. 2007; 122(3):699-704. DOI: 10.1002/ijc.23153. View

17.

Su R, Cao S, Ma J, Liu Y, Liu X, Zheng J . Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122. Mol Cancer. 2017; 16(1):171. PMC: 5683208. DOI: 10.1186/s12943-017-0737-1. View

18.

Liu Q, Yu W, Zhu S, Cheng K, Xu H, Lv Y . Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p. J Cell Physiol. 2018; 234(1):757-768. DOI: 10.1002/jcp.26889. View

19.

Yu L, Gui S, Liu Y, Qiu X, Zhang G, Zhang X . Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2. Aging (Albany NY). 2019; 11(15):5300-5318. PMC: 6710058. DOI: 10.18632/aging.102092. View

20.

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View